Crossmark

Breitere Zulassung für Osimertinib

Crossref DOI link: https://doi.org/10.1007/s15004-025-0905-1

Published Online: 2025-03-21

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmale, Ine
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-01
More Information

Article History

First Online: 21 March 2025

Free to read: This content has been made available to all.